PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30459358-0	2019	Eicosapentaenoic acid in combination with EPHA2 inhibition shows efficacy in preclinical models of triple-negative breast cancer by disrupting cellular cholesterol efflux.	Cholesterol	152-163	EPH receptor A2	Homo sapiens	42-47	
35227773-13	2022	Metabolic signature of EPHA2 and ACLY stable knockdown HCC cells demonstrated significant overlap in fatty acids, cholesterol and TCA cycle metabolite profiles.	Cholesterol	114-125	EPH receptor A2	Homo sapiens	23-28